Bolder Biotechnology, Inc.
Records under this name other than the patents Bolder Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Bolder Biotechnology, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,229,683 | Hematopoietic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure Formerly held In force · High confidence | In force | High confidence | |
| US 12,274,736 | Hematopoietic Growth Factor Proteins and Analogs Thereof and Angiotensin Converting Enzyme Inhibitors for Treatment of Radiation Exposure Formerly held In force · High confidence | In force | High confidence | |
| US 7,306,931 | Method for Refolding Proteins Containing Free Cysteine Residues Term ended Term ended Aug 15, 2022 · High confidence | Term ended | Term ended Aug 15, 2022 | High confidence |
| US 7,754,855 | Immunoglobulin fusion proteins Lapsed on the fee record Ended Jul 13, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 13, 2022 | USPTO record |
| US 6,753,165 | Methods for making proteins containing free cysteine residues Term ended Term ended Sep 6, 2021 · USPTO record | Term ended | Term ended Sep 6, 2021 | USPTO record |
| US 7,732,572 | Cysteine variants of alpha interferon-2 Term ended Term ended Nov 9, 2020 · USPTO record | Term ended | Term ended Nov 9, 2020 | USPTO record |
| US 7,629,314 | Methods for making proteins containing free cysteine residues Term ended Term ended Aug 9, 2020 · USPTO record | Term ended | Term ended Aug 9, 2020 | USPTO record |
| US 7,399,839 | Monopegylated growth hormone proteins Lapsed on the fee record Ended Jul 15, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 15, 2020 | USPTO record |
| US 8,932,828 | Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins Term ended Ended no later than May 16, 2020 · USPTO record | Term ended | Ended no later than May 16, 2020 | USPTO record |
| US 6,608,183 | Derivatives of growth hormone and related proteins Term ended Term ended Jan 14, 2020 · USPTO record | Term ended | Term ended Jan 14, 2020 | USPTO record |